Metraipolis › archive › dc_e9cfe89e9ebf

Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders — Europe PMC PMID:41012445

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012445
DOI
10.3390/pharmaceutics17091106
License (as archived)
solo-consultazione
Archived
2026-11-10T08:37:02.776Z
SHA-256 of the archived text
3e6bc5658311a0dda82a9602a57cd8b6a6f6542ce2ba5f6ea636ec5003db0d91
Stable URL of this page
https://metraipolis.com/documento/dc_e9cfe89e9ebf

How to cite

Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders — Europe PMC PMID:41012445 — Europe PMC (en), https://europepmc.org/article/MED/41012445 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e9cfe89e9ebf (Metraipolis archive dc_e9cfe89e9ebf, sha256 3e6bc5658311a0dda82a9602a57cd8b6a6f6542ce2ba5f6ea636ec5003db0d91)
BibTeX
@misc{dce9cfe89e9ebf,
  title = {Aptamer-Nanoconjugates as Potential Theranostics in Major Neuro-Oncological and Neurodegenerative Disorders — Europe PMC PMID:41012445},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012445},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e9cfe89e9ebf; sha256 3e6bc5658311a0dda82a9602a57cd8b6a6f6542ce2ba5f6ea636ec5003db0d91},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012445. Agents can read the archived copy with the MCP tool read_document.